ST-elevation Myocardial Infarction Clinical Trial
Official title:
Target Temperature Management In Myocardial Infarction - A Pilot Study
The primary goal in the treatment of acute myocardial infarction is to reperfuse the
ischemic myocardium to reduce infarct size. Animal data and human data suggest that
whole-body cooling to temperatures below 35°C before revascularisation can additionally
reduce infarct size and therefore improves outcome in these patients.
The purpose of the study is to determine the feasibility and safety of a combined cooling
strategy started in the out-of-hospital arena for achieving pre-reperfusion hypothermia in
patients with acute st-elevation myocardial infarction.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00962416 -
Comparison of Biomatrix Versus Gazelle in ST-Elevation Myocardial Infarction (STEMI)
|
Phase 4 | |
| Active, not recruiting |
NCT00927615 -
Comparison of Intracoronary Versus Intravenous Abciximab in ST-segment Elevation Myocardial Infarction (CICERO)
|
N/A | |
| Completed |
NCT03135275 -
MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial
|
N/A | |
| Recruiting |
NCT02592694 -
Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty
|
Phase 4 | |
| Withdrawn |
NCT01991366 -
Should Integrilin be an Integral Part of Adjunctive Therapy in Patients Undergoing Primary PCI for ST-Elevation MI?
|
||
| Completed |
NCT02158468 -
Effect of Conditioning on Myocardial Damage in STEMI
|
N/A | |
| Completed |
NCT01197729 -
OPTAMI (Optimized Therapy of Acute Myocardial Infarction) - Registry
|
N/A | |
| Completed |
NCT01882179 -
Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
|
Phase 3 | |
| Terminated |
NCT00719914 -
A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks
|
Phase 2 | |
| Completed |
NCT00952224 -
Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance - Impact on Outcome
|
N/A | |
| Completed |
NCT00378391 -
European Registry on STEMI Patients Transferred for PCI With Upstream Use of Abciximab - EuroTransfer Registry
|
N/A | |
| Withdrawn |
NCT04303377 -
Early Treatment With Evolocumab in Patients With ST-elevation Myocardial Infarction
|
Phase 2 | |
| Completed |
NCT03523624 -
Factor XIII and Other Biomarkers in ST Segment Elevation Myocardial Infarction
|
||
| Completed |
NCT01531114 -
PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus
|
Phase 3 | |
| Active, not recruiting |
NCT01960933 -
Primary PCI in Patients With ST-elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization
|
N/A | |
| Completed |
NCT00502528 -
Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction
|
Phase 2 | |
| Recruiting |
NCT02062554 -
Brasilia Heart Study
|
||
| Recruiting |
NCT04150016 -
In-stent Repair and Vessel Reaction of STEMI Patients With OCT
|
N/A | |
| Recruiting |
NCT03074214 -
Prognostic Value of Copeptin for Infarct Size and Prognosis in Patients With ST-elevation Myocardial Infarction
|
N/A | |
| Not yet recruiting |
NCT05231226 -
Timing of Complete Revascularization in Patients With ST-segment Elevation Myocardial Infarction And Multivessel Disease
|
N/A |